Cited by 62

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study

Schneider, Raphael, McKeever, Paul, Kim, TaeHyung, Graff, Caroline, van Swieten, John Cornelis, Karydas, Anna, Boxer, Adam, Rosen, Howie, Miller, Bruce L, Laforce Jr, Robert, Galimberti, Daniela, Masellis, Mario, Borroni, Barbara, Zhang, Zhaolei, Zinman, Lorne, Rohrer, Jonathan Daniel, Tartaglia, Maria Carmela, Robertson, Janice·2018·Journal of Neurology, Neurosurgery & Psychiatry

Abstract

Objective: To determine whether exosomal microRNAs (miRNAs) in cerebrospinal fluid (CSF) of patients with frontotemporal dementia (FTD) can serve as diagnostic biomarkers, we assessed miRNA expression in the Genetic Frontotemporal Dementia Initiative (GENFI) cohort and in sporadic FTD. Methods: GENFI participants were either carriers of a pathogenic mutation in progranulin, chromosome 9 open reading frame 72 or microtubule-associated protein tau or were at risk of carrying a mutation because a first-degree relative was a known symptomatic mutation carrier. Exosomes were isolated from CSF of 23 presymptomatic and 15 symptomatic mutation carriers and 11 healthy non-mutation carriers. Expression of 752 miRNAs was measured using quantitative PCR (qPCR) arrays and validated by qPCR using individual primers. MiRNAs found differentially expressed in symptomatic compared with presymptomatic mutation carriers were further evaluated in a cohort of 17 patients with sporadic FTD, 13 patients with sporadic Alzheimer’s disease (AD) and 10 healthy controls (HCs) of similar age. Results: In the GENFI cohort, miR-204-5p and miR-632 were significantly decreased in symptomatic compared with presymptomatic mutation carriers. Decrease of miR-204-5p and miR-632 revealed receiver operator characteristics with an area of 0.89 (90% CI 0.79 to 0.98) and 0.81 (90% CI 0.68 to 0.93), respectively, and when combined an area of 0.93 (90% CI 0.87 to 0.99). In sporadic FTD, only miR-632 was significantly decreased compared with AD and HCs. Decrease of miR-632 revealed an area of 0.90 (90% CI 0.81 to 0.98). Conclusions: Exosomal miR-204-5p and miR-632 have potential as diagnostic biomarkers for genetic FTD and miR-632 also for sporadic FTD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jnnp-2017-317492

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 4 references

Research works printed but not linked: 38

  1. 10.1016/S0140-6736(15)00461-4 · DOI · Paper page
  2. Maloney, 2016, Epigenetics of dementia: understanding the disease as a transformation rather than a state, Lancet Neurol, 15, 760, 10.1016/S1474-4422(16)00065-X · DOI
  3. 10.1093/brain/awg204 · DOI
  4. 10.1093/hmg/ddn257 · DOI
  5. Kocerha, 2011, Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations, BMC Genomics, 12, 527, 10.1186/1471-2164-12-527 · DOI
  6. 10.1523/JNEUROSCI.0521-12.2012 · DOI · Paper page
  7. Bracken, 2016, A network-biology perspective of microRNA function and dysfunction in cancer, Nat Rev Genet, 17, 719, 10.1038/nrg.2016.134 · DOI
  8. 10.1016/0304-3835(83)90040-X · DOI
  9. Ratajczak, 2016, Horizontal transfer of RNA and proteins between cells by extracellular microvesicles: 14 years later, Clin Transl Med, 5, 7, 10.1186/s40169-016-0087-4 · DOI
  10. 10.1073/pnas.0914843107 · DOI
  11. 10.1523/JNEUROSCI.6476-10.2011 · DOI · Paper page
  12. 10.1016/j.mcn.2010.11.004 · DOI
  13. 10.1002/stem.1129 · DOI
  14. 10.1074/jbc.M112.410944 · DOI · Paper page
  15. 10.1016/j.ccell.2016.10.009 · DOI · Paper page
  16. Gallo A , Tandon M , Alevizos I , et al . The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 2012;7:e30679. doi:10.1371/journal.pone.0030679 · DOI · Paper page
  17. Cheng, 2014, Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood, J Extracell Vesicles, 3, 23743, 10.3402/jev.v3.23743 · DOI · Paper page
  18. 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  19. 10.1093/brain/awr179 · DOI · Paper page
  20. 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
  21. 10.1016/0022-510X(94)90191-0 · DOI
  22. 10.1016/j.jalz.2011.03.005 · DOI · Paper page
  23. 10.1186/2051-5960-1-42 · DOI
  24. 10.1006/meth.2001.1262 · DOI · Paper page
  25. 10.1038/nmeth.3485 · DOI
  26. 10.1093/nar/gkw1092 · DOI · Paper page
  27. 10.1093/emboj/16.7.1686 · DOI
  28. 10.1016/j.neuron.2011.07.021 · DOI · Paper page
  29. Alquézar, 2016, Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers, J Psychiatry Neurosci, 41, 225, 10.1503/jpn.150131 · DOI
  30. 10.1038/jhg.2016.91 · DOI
  31. Sørensen, 2016, miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia - an exploratory study, Transl Neurodegener, 5, 6, 10.1186/s40035-016-0053-5 · DOI
  32. 10.1016/j.neuron.2011.09.002 · DOI
  33. Xia Q , Hu Q , Wang H , et al . Induction of COX-2-PGE2 synthesis by activation of the MAPK/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia. Cell Death Dis 2015;6:e1702. doi:10.1038/cddis.2015.69 · DOI
  34. 10.1093/hmg/ddq100 · DOI
  35. 10.1016/j.neuron.2010.09.034 · DOI · Paper page
  36. 10.1007/s00401-015-1448-6 · DOI
  37. 10.1016/S0304-3940(99)00937-4 · DOI
  38. 10.1186/1750-1326-7-33 · DOI

Cited by

Sorted by citations

See all 62

Metadata

Authors
Schneider, R., McKeever, P., Kim, T., Graff, C., van Swieten, J. C., Karydas, A., Boxer, A., Rosen, H., Miller, B. L., Laforce Jr, R., Galimberti, D., Masellis, M., Borroni, B., Zhang, Z., Zinman, L., Rohrer, J. D., Tartaglia, M. C., & Robertson, J.
Venue
Journal of Neurology, Neurosurgery & Psychiatry
Publisher
BMJ
Published
2018-02-06
Volume
89
Issue
8
Pages
851-858
ISSN
  • 0022-3050
  • 1468-330X
Cited by
62
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review